HSPB8 and breast carcinoma: Silencing of HSPB8 notably curtails MCF-7 cell proliferation and negates the proliferative impetus of 17β-estradiol, intimating a probable role for HSPB8 in the proliferative and migratory mechanisms governing breast cancer 4.